Point72 Asset Management
NSPR icon

Point72 Asset Management’s InspireMD NSPR Stock Holding History

Point72 Asset Management’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-219,093
Closed -$716K – 2604
2023
Q3 		$716K Buy
+219,093
New +$700K ﹤0.01% 1428

Other funds holding NSPR

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.18B AUM 18.43% 1-Year Est. Return

Point72 Asset Management's NSPR Position: Q4 2023 in Review

Point72 Asset Management sold out of InspireMD (NSPR) in Q4 2023, closing a stake of 219,093 shares — an estimated $716K sold.

Point72 Asset Management first reported a position in NSPR in Q3 2023 and held it in 1 quarter. The position peaked at $716K in Q3 2023. 29 funds tracked by Wall St. Rank hold NSPR as of Q4 2023.

  • Point72 Asset Management reported no remaining InspireMD position as of Q4 2023 after selling out during the quarter.
  • Point72 Asset Management sold 219,093 InspireMD shares in Q4 2023, an estimated $716K.
  • Point72 Asset Management first reported a position in InspireMD in Q3 2023 and held it in 1 quarter.
  • Point72 Asset Management's InspireMD position peaked at $716K in Q3 2023.
  • 29 funds tracked by Wall St. Rank held InspireMD as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.